These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7923826)

  • 81. Thyrotoxic periodic paralysis in Chinese patients: milder thyrotoxicosis yet lower dose of (131)I should be avoided.
    Long W; Lin Y
    Clin Nucl Med; 2013 Apr; 38(4):248-51. PubMed ID: 23429401
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Genome-wide association study identifies a susceptibility locus for thyrotoxic periodic paralysis at 17q24.3.
    Cheung CL; Lau KS; Ho AY; Lee KK; Tiu SC; Lau EY; Leung J; Tsang MW; Chan KW; Yeung CY; Woo YC; Cheung EY; Hung VH; Pang HK; Hung CS; Sham PC; Kung AW
    Nat Genet; 2012 Sep; 44(9):1026-9. PubMed ID: 22863731
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis.
    Lu KC; Hsu YJ; Chiu JS; Hsu YD; Lin SH
    Am J Emerg Med; 2004 Nov; 22(7):544-7. PubMed ID: 15666258
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Thyrotoxic hypokalaemic periodic paralysis in a man from Nepal.
    Majhi S; Mehta KD; Rohil V
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21894247
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A rare case of thyrotoxic periodic paralysis precipitated by hydrocortisone.
    Chakrabarti S
    J Nat Sci Biol Med; 2015; 6(1):271-4. PubMed ID: 25810683
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Platelet sodium and potassium ATPase [corrected] activity and noradrenaline efflux rate in relation to autonomic and peripheral nerve function in insulin-dependent diabetic patients.
    Bergström B; Mattiasson I; Rosén I; Lilja B; Sundkvist G
    J Intern Med; 1989 Mar; 225(3):185-90. PubMed ID: 2539427
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Three cases of thyrotoxic periodic paralysis due to painless thyroiditis.
    Sanyal D; Raychaudhuri M; Bhattacharjee S
    Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S162-3. PubMed ID: 24251144
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Thyrotoxic Hypokalemic Periodic Paralysis.
    Sonkar SK; Kumar S; Singh NK
    Indian J Crit Care Med; 2018 May; 22(5):378-380. PubMed ID: 29910553
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluating the efficacy of primary treatment for graves' disease complicated by thyrotoxic periodic paralysis.
    Chang RY; Lang BH; Chan AC; Wong KP
    Int J Endocrinol; 2014; 2014():949068. PubMed ID: 25147568
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Thyrotoxic Periodic Paralysis- A Diagnostically Challenging Rare Clinical Entity.
    Gadela NV; Madgula AS; Drekolias D; Paravathaneni M; Modi V
    Cureus; 2020 Nov; 12(11):e11804. PubMed ID: 33409049
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A metabolic link between the astrocytic α2-Na/K ATPase and episodic paralysis.
    Inglis GAS
    Commun Biol; 2021 Feb; 4(1):184. PubMed ID: 33547402
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cellular sodium pumps in hypokalaemic periodic muscle paralysis.
    Taylor EA; Oh VM
    Clin Sci (Lond); 1996 Sep; 91(3):261-4. PubMed ID: 8869406
    [No Abstract]   [Full Text] [Related]  

  • 93. Thyrotoxic periodic paralysis in an adolescent male: A case report and literature review.
    He L; Lawrence V; Moore WV; Yan Y
    Clin Case Rep; 2021 Jan; 9(1):465-469. PubMed ID: 33489198
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ecstasy-induced thyrotoxic periodic paralysis.
    Forrest L; Platts J
    BMJ Case Rep; 2009; 2009():. PubMed ID: 22190983
    [TBL] [Abstract][Full Text] [Related]  

  • 95. THYROTOXIC PERIODIC PARALYSIS, β2-ADRENERGIC BRONCHODILATOR, AND INSULIN—AN INTERESTING INTERPLAY.
    Senthilkumaran S; Nath Jena N; Jayaraman S; Thirumalaikolundusubramanian P
    CJEM; 2014 Sep; 16(5):343. PubMed ID: 25227640
    [No Abstract]   [Full Text] [Related]  

  • 96. IN REPLY TO "THYROTOXIC PERIODIC PARALYSIS, β2-ADRENERGIC BRONCHODILATOR, AND INSULIN—AN INTERESTING INTERPLAY".
    Cheng CJ; Lin SH
    CJEM; 2014 Sep; 16(5):344. PubMed ID: 25227641
    [No Abstract]   [Full Text] [Related]  

  • 97. Retracted: Thyrotoxic Periodic Paralysis: Clinical Challenges.
    Research JOT
    J Thyroid Res; 2021; 2021():7814159. PubMed ID: 33815741
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Thyrotoxic periodic paralysis.
    Lam L; Nair RJ; Tingle L
    Proc (Bayl Univ Med Cent); 2006 Apr; 19(2):126-9. PubMed ID: 16609738
    [No Abstract]   [Full Text] [Related]  

  • 99. Hypokalaemic thyrotoxic periodic paralysis.
    Volpé R
    J R Soc Med; 1981 Feb; 74(2):170. PubMed ID: 20894339
    [No Abstract]   [Full Text] [Related]  

  • 100. A cytochrome b model, [Fe(TPP)(4-MeHIm)(2)][K(222-cryptand)](2)Cl(2).
    Silvernail NJ; Noll BC; Scheidt WR
    Acta Crystallogr Sect E Struct Rep Online; 2005 Jun; 61(6):m1201-m1203. PubMed ID: 18449359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.